Drug Information Session 2: Dosage-Form Query

1. Aim

To practise drug information 2 of 4 using an explicitly assumed teaching scenario or a supervised de-identified case. An actual patient session must be entered in the student record.

2. Requirements

Assumed teaching scenario or consented de-identified clinical record, verified medicine and laboratory sources, local policy, observation form, supervisor, and private setting. Actual patient details, medicine strengths, dose instructions, laboratory intervals, and software must be entered in the student record.

3. Theory

An assumed nurse asks whether an assumed oral product can be altered for administration. The answer depends on the exact brand, release mechanism, route, product information, and suitable alternatives. No product should be crushed or opened on the basis of a generic rule.

4. Procedure

Confirm this session number, teaching or actual status, consent and privacy requirements, and supervisor.
List verified facts separately from assumed scenario details and missing information.
Perform the supervised reasoning or communication task: Identify the exact product, check manufacturer or official labelling and local administration policy, document alternatives, and have the supervising pharmacist approve the response.
Record exact source titles and dates, any limitation, and the supervisor feedback.
Do not give a patient-specific instruction from an assumed case; seek qualified clinical review before any recommendation.
Document the learning outcome and whether a real supervised encounter occurred.

5. Observation and calculation

Student record field	Entry
Case or product	Record here
Method	Record here
Observation	Record here
Inference	Record here
Supervisor check	Record here
Outcome	Record here

Assumed teaching scenario only: An assumed medicine is described only as a tablet. That invented description is insufficient to decide whether it can be altered. Every invented fact and observation is assumed. This is not a real patient encounter or clinical recommendation.

6. Output or final result

Submit a labelled product identity checklist and a supervisor-reviewed learning record. Actual session completion and patient outcome: Record here.

Teaching-lab safety: Protect patient confidentiality, use consent and local supervision, and escalate urgent or uncertain clinical questions through the responsible care team. Do not enter assumed details into a patient chart.

This page is a supervised-activity guide; it does not report a completed case.

7. Sources

← Drug Information Session 1: Interaction QueryDrug Information Session 3: Suspected Adverse Effect →

Back to Clinical Pharmacy Practicals · All Pharm D Practicals · Pharm D

Theory notes: Pharm D Year 4, 4.3 Clinical Pharmacy